WILLEM OVERWIJK to Recombinant Proteins
This is a "connection" page, showing publications WILLEM OVERWIJK has written about Recombinant Proteins.
Connection Strength
0.016
-
Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC. Prostate. 2002 Nov 01; 53(3):183-91.
Score: 0.009
-
Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J Natl Cancer Inst. 1999 Jan 20; 91(2):169-75.
Score: 0.007